Cardio Diagnostics Holdings, Inc.(CDIO)

Biotechnology · Chicago, IL

$2.01-0.06 (-2.67%)

Delayed quote: Oct 6, 2026, 3:59 PM EDT

Operating Cash Flow Yield: N/A

Basis: Four-quarter operating cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.

The operating cash flow yield is N/A as of 2026-10-06T20:01:33.817Z.

Stored calculation inputs

Calculation as of: 2026-10-06T20:01:33.817Z.

Quote observation: 2026-10-06T19:59:56.000Z. Amounts in USD. The price header may show a later quote.

TTM operating cash flow · period ending 2026-06-30: -5,659,843
Quote market capitalization: 5,933,735

FMP input reference: 9b4bc62a31f75b1a016fc6ea0dc71fcb65437a541a8d62a03c8decabfd044c64

P/OCF Ratio|FCF Yield|Earnings Yield|EBITDA Yield|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

CDIO Operating Cash Flow Yield Metrics

OPERATING CASH FLOW YIELD

N/A

CDIO Competitors' Operating Cash Flow Yield

CDIO

Cardio Diagnostics Holdings, Inc.

Current

Market Cap

$5.93M

Operating Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

SNOA

Sonoma Pharmaceuticals, Inc.

vs CDIO

Market Cap

$5.89M

Operating Cash Flow Yield

N/A

TTM Avg

6.96%

3Y Avg

6.96%

5Y Avg

6.96%

CUPR

Cuprina Holdings (Cayman) Limited Class A Ordinary Shares

vs CDIO

Market Cap

$5.82M

Operating Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

LUCY

Lucyd, Inc

vs CDIO

Market Cap

$5.80M

Operating Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

SCNX

Scienture Holdings, Inc.

vs CDIO

Market Cap

$6.11M

Operating Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ENLV

Enlivex Therapeutics Ltd.

vs CDIO

Market Cap

$5.73M

Operating Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NVNO

enVVeno Medical Corporation

vs CDIO

Market Cap

$5.66M

Operating Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ACXP

Acurx Pharmaceuticals, Inc.

vs CDIO

Market Cap

$5.63M

Operating Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

FEMY

Femasys Inc.

vs CDIO

Market Cap

$6.28M

Operating Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

BMRA

Biomerica, Inc.

vs CDIO

Market Cap

$6.40M

Operating Cash Flow Yield

N/A

TTM Avg

0.85%

3Y Avg

0.85%

5Y Avg

0.85%

NAME	MARKET CAP	OPERATING CASH FLOW YIELD	TTM	3Y	5Y
Cardio Diagnostics Holdings, Inc. (CDIO)	$5.93M	N/A	N/A	N/A	N/A
Sonoma Pharmaceuticals, Inc. (SNOA)vs ›	$5.89M	N/A	6.96%	6.96%	6.96%
Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR)vs ›	$5.82M	N/A	N/A	N/A	N/A
Lucyd, Inc (LUCY)vs ›	$5.80M	N/A	N/A	N/A	N/A
Scienture Holdings, Inc. (SCNX)vs ›	$6.11M	N/A	N/A	N/A	N/A
Enlivex Therapeutics Ltd. (ENLV)vs ›	$5.73M	N/A	N/A	N/A	N/A
enVVeno Medical Corporation (NVNO)vs ›	$5.66M	N/A	N/A	N/A	N/A
Acurx Pharmaceuticals, Inc. (ACXP)vs ›	$5.63M	N/A	N/A	N/A	N/A
Femasys Inc. (FEMY)vs ›	$6.28M	N/A	N/A	N/A	N/A
Biomerica, Inc. (BMRA)vs ›	$6.40M	N/A	0.85%	0.85%	0.85%

Operating Cash Flow Yield Formula & Definition

OCF Yield = TTM Operating Cash Flow / Market Cap

Operating cash flow yield is the inverse of P/OCF, expressing trailing operating cash flow as a percentage of price. It sits between earnings yield (before non-cash accrual effects) and FCF yield (before capital expenditure).

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Operating Cash Flow Yield: N/A

CDIO Operating Cash Flow Yield Metrics

CDIO Competitors' Operating Cash Flow Yield

Operating Cash Flow Yield Formula & Definition

Related Metrics